Oaktree Acquisition Corp. II
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OACC research report →
Price Chart
About the company
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
- CEO
- Zaid Pardesi
- IPO
- 2024
- Employees
- 3
- HQ
- Los Angeles, CA, US
Get TickerSpark's AI analysis on OACC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $264.51M
- P/E
- 38.05
- PEG
- 0.95
- P/S
- 0.00
- P/B
- 1.04
- EV/EBITDA
- -219.53
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 3.46%
- ROIC
- -0.59%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-1,195,687
- Net Income
- $7.29M+273607.2%
- EPS
- $0.30+453.5%
- OCF Growth
- -235698.3%
- FCF Growth
- -235698.3%
- 52W High
- $10.88
- 52W Low
- $10.50
- 50D MA
- $10.76
- 200D MA
- $10.68
- Beta
- -0.04
- RSI (14)
- 46
- Avg Volume
- 26.85K
No earnings-call transcripts are available for OACC yet.
- Free Float
- 80.5%
- Shares Outstanding
- 24.58M
- Float Shares
- 19.78M
of shares held by institutions
51 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Aqr Arbitrage LLC | 1.32M | 0 |
| Fort Baker Capital Management LP | 1.11M | ▲ 105.39K |
| Decagon Asset Management Llp | 1.09M | ▲ 88.90K |
| Empyrean Capital Partners, LP | 900.00K | 0 |
| D. E. Shaw & Co., Inc. | 861.63K | 0 |
| Boussard & Gavaudan Gestion Sas | 720.00K | ▲ 720.00K |
| Boussard & Gavaudan Investment Management Llp | 720.00K | 0 |
| Linden Advisors LP | 600.00K | 0 |
| Toronto Dominion Bank | 554.29K | ▲ 57.64K |
| Sculptor Capital LP | 530.81K | 0 |
| Goldman Sachs Group Inc | 529.53K | 0 |
| Moore Capital Management, LP | 525.00K | 0 |
Held by 2 ETFs
Biggest fund positions in OACC by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 29, 25 | Martinez George Arthur | other | 0 |
| Oct 17, 25 | BERRY DAVID A | other | 0 |
| Jun 3, 25 | Sweeney Thomas | other | 0 |
| Oct 30, 24 | Oaktree Acquisition Holdings III LS, LLC | other | 231,492 |
| Oct 30, 24 | Oaktree Acquisition Holdings III LS, LLC | other | 33,981 |
| Oct 30, 24 | Oaktree Acquisition Holdings III LS, LLC | other | 6,796 |
| Oct 30, 24 | Oaktree Acquisition Holdings III LS, LLC | other | 33,981 |
| Oct 23, 24 | Oaktree Acquisition Holdings III LS, LLC | other | 0 |
| Oct 23, 24 | Oaktree Acquisition Holdings III LS, LLC | other | 52,500 |
| Oct 23, 24 | Oaktree Acquisition Holdings III LS, LLC | other | 110,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our OACC coverage
Recent articles, reports, and earnings notes.
No research on OACC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OACC report →Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Stock Price Down 0.2% – Here’s Why
defenseworld.net · Apr 10
Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Stock Price Up 0.4% – Time to Buy?
defenseworld.net · Jan 9
Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Shares Up 0.3% – Still a Buy?
defenseworld.net · Dec 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.